Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 3

1(33.3%)

3Total

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07484685Not ApplicableRecruiting

Reduced Time Interval for Implant Placement After Extraction Socket Preservation Using the Vega Plus Implants

Role: lead

NCT06501729Not ApplicableCompleted

Kissing as a Protective Factor Against Acidic pH in Saliva

Role: lead

NCT04576299Completed

Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic

Role: collaborator

NCT04486404Completed

Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America

Role: collaborator

NCT05198414Completed

SER+ Against COVID-19 - Interventions to Strengthen the Resilience of HCWs in Ecuador

Role: collaborator

NCT04592263Completed

Patient Centered Care in Diabetes in Ecuador

Role: collaborator

NCT04362969Unknown

COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador

Role: collaborator

NCT04351932Phase 3Unknown

Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

Role: lead

All 8 trials loaded